Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
Open Access
- 5 July 2012
- journal article
- laboratory investigation
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 109 (3), 467-475
- https://doi.org/10.1007/s11060-012-0923-3
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell linesJournal of Neuro-Oncology, 2011
- Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport ChainPublished by Elsevier BV ,2010
- Interaction of Hypoxia-Inducible Factor-1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and FateThe International Journal of Cell Cloning, 2010
- Chemo-Resistant Protein Expression Pattern of Glioblastoma Cells (A172) to Perillyl AlcoholJournal of Proteome Research, 2010
- Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazoleBMC Cancer, 2010
- Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stromaBMC Cancer, 2009
- Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma ModelPLOS ONE, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant GliomaJournal of Clinical Oncology, 2009
- Hyperoxia-induced signal transduction pathways in pulmonary epithelial cellsFree Radical Biology & Medicine, 2007